Y-Mabs Therapeutics Inc

+0.16 (+3.83%)
5:33:59 PM EDT: $4.49 +0.15 (+3.46%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)189.52M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$19.61 Million
Adjusted EPS-$0.49
See more estimates
10-Day MA$4.31
50-Day MA$9.69
200-Day MA$12.29
See more pivots

Y-Mabs Therapeutics Inc Stock, NASDAQ:YMAB

230 Park Avenue, Suite 3350, New York, New York 10169-0005
United States of America
Phone: +1.646.885.8505
Number of Employees: 148


Y-mAbs Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on the development and commercialization of antibody based therapeutic products for the treatment of cancer. Its services include discovery, protein engineering, clinical and regulatory. Y-mAbs Therapeutics was founded by Thomas Gad in April 2015 and is headquartered in New York, NY.